Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats

Free Radical Biology and Medicine

Volumn 50, Issue 2, 2011, Pages 345-353

  Collino, Massimo ^a   Benetti, Elisa ^a   Miglio, Gianluca ^a   Castiglia, Sara ^a   Rosa, Arianna Carolina ^a   Aragno, Manuela ^a   Thiemermann, Christoph ^b   Fantozzi, Roberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Diabetes; Free radicals; GSK0660; GW0742; Ischemia reperfusion; Kidney; PPAR ; SOCS 3

Indexed keywords

[4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; GSK 0660; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; STREPTOZOCIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DRUG MECHANISM; DRUG RECEPTOR BINDING; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY; MALE; PEROXIDASE; PPAR DELTA; PPAR-BETA; RATS; RATS, WISTAR; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLES;

RATTUS;

EID: 78651247523     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.10.710     Document Type: Article

References (45)

1. J.G. Abuelo Normotensive ischemic acute renal failure N. Engl. J. Med. 357 2007 797 805
2. M. Leblanc, J.A. Kellum, R.T. Gibney, W. Lieberthal, J. Tumlin, and R. Mehta Risk factors for acute renal failure: inherent and modifiable risks Curr. Opin. Crit. Care 11 2005 533 536
3. H. Shi, D. Patschan, T. Epstein, M.S. Goligorsky, and J. Winaver Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury Am. J. Physiol. Renal Physiol. 293 2007 F1512 F1517
4. B. Schmekal, R. Pichler, and G. Biesenbach Causes and prognosis of nontraumatic acute renal failure requiring dialysis in adult patients with and without diabetes Renal Fail. 26 2004 39 43
5. J. Melin, O. Hellberg, and B. Fellstrom Hyperglycaemia and renal ischaemia-reperfusion injury Nephrol. Dial. Transplant. 18 2003 460 462
6. A. Ishani, J.L. Xue, J. Himmelfarb, P.W. Eggers, P.L. Kimmel, B.A. Molitoris, and A.J. Collins Acute kidney injury increases risk of ESRD among elderly J. Am. Soc. Nephrol. 20 2009 223 228
7. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
8. J.J. Friedewald, and H. Rabb Inflammatory cells in ischemic acute renal failure Kidney Int. 66 2004 486 491
9. P. Hernandez-Vargas, O. Lopez-Franco, G. Sanjuan, M. Ruperez, G. Ortiz-Munoz, Y. Suzuki, P. Aguado-Roncero, G. Perez-Tejerizo, J. Blanco, J. Egido, M. Ruiz-Ortega, and C. Gomez-Guerrero Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells J. Am. Soc. Nephrol. 16 2005 1673 1683
10. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
11. T. Yang, D.E. Michele, J. Park, A.M. Smart, Z. Lin, F.C. Brosius III, J.B. Schnermann, and J.P. Briggs Expression of peroxisomal proliferator- activated receptors and retinoid X receptors in the kidney Am. J. Physiol. 277 1999 F966 F973
12. P.K. Chatterjee Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review Naunyn Schmiedebergs Arch. Pharmacol. 376 2007 1 43
13. M. Collino, N.S. Patel, K.M. Lawrence, M. Collin, D.S. Latchman, M.M. Yaqoob, and C. Thiemermann The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion Kidney Int. 68 2005 529 536
14. N.S. Patel, R. di Paola, E. Mazzon, D. Britti, C. Thiemermann, and S. Cuzzocrea Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury J. Pharmacol. Exp. Ther. 328 2009 635 643
15. S. Li, A. Basnakian, R. Bhatt, J. Megyesi, N. Gokden, S.V. Shah, and D. Portilla PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G Am. J. Physiol. Renal Physiol. 287 2004 F990 F998
16. S. Li, K.K. Nagothu, V. Desai, T. Lee, W. Branham, C. Moland, J.K. Megyesi, M.D. Crew, and D. Portilla Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury Kidney Int. 76 2009 1049 1062
17. E. Letavernier, J. Perez, E. Joye, A. Bellocq, B. Fouqueray, J.P. Haymann, D. Heudes, W. Wahli, B. Desvergne, and L. Baud Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure J. Am. Soc. Nephrol. 16 2005 2395 2402
18. M.L. Sznaidman, C.D. Haffner, P.R. Maloney, A. Fivush, E. Chao, D. Goreham, M.L. Sierra, C. LeGrumelec, H.E. Xu, V.G. Montana, M.H. Lambert, T.M. Willson, W.R. Oliver Jr., and D.D. Sternbach Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)-synthesis and biological activity Bioorg. Med. Chem. Lett. 13 2003 1517 1521
19. B.G. Shearer, D.J. Steger, J.M. Way, T.B. Stanley, D.C. Lobe, D.A. Grillot, M.A. Iannone, M.A. Lazar, T.M. Willson, and A.N. Billin Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist Mol. Endocrinol. 22 2008 523 529
20. N.S. Patel, S. Cuzzocrea, M. Collino, P.K. Chaterjee, E. Mazzon, D. Britti, M.M. Yaqoob, and C. Thiemermann The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo Eur. J. Pharmacol. 562 2007 148 154
21. A. Kapoor, M. Collino, S. Castiglia, R. Fantozzi, and C. Thiemermann Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat Shock 34 2009 117 124
22. R.J. Mitchell Improved method for specific determination of creatinine in serum and urine Clin. Chem. 19 1973 408 410
23. P.K. Chatterjee, and C. Thiemermann An in vivo model of ischemia/reperfusion and inflammation of the kidneys of the rat Methods Mol. Biol. 225 2003 223 237
24. C. Bazzi, C. Petrini, V. Rizza, G. Arrigo, P. Napodano, M. Paparella, and G. D'Amico Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis Nephrol. Dial. Transplant. 17 2002 1890 1896
25. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J. Invest. Dermatol. 78 1982 206 209
26. P. Tripatara, N.S. Patel, M. Collino, M. Gallicchio, J. Kieswich, S. Castiglia, E. Benetti, K.N. Stewart, P.A. Brown, M.M. Yaqoob, R. Fantozzi, and C. Thiemermann Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction Lab. Invest. 88 2008 1038 1048
27. W.K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J.V. Bonventre Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury Kidney Int. 62 2002 237 244
28. R. Haverslag, G. Pasterkamp, and I.E. Hoefer Targeting adhesion molecules in cardiovascular disorders Cardiovasc. Hematol. Disord. Drug Targets 8 2008 252 260
29. A. Yoshimura, T. Naka, and M. Kubo SOCS proteins, cytokine signalling and immune regulation Nat. Rev. Immunol. 7 2007 454 465
30. V.S. Vaidya, G.M. Ford, S.S. Waikar, Y. Wang, M.B. Clement, V. Ramirez, W.E. Glaab, S.P. Troth, F.D. Sistare, W.C. Prozialeck, J.R. Edwards, N.A. Bobadilla, S.C. Mefferd, and J.V. Bonventre A rapid urine test for early detection of kidney injury Kidney Int. 76 2009 108 114
31. J. Melin, O. Hellberg, E. Larsson, L. Zezina, and B.C. Fellstrom Protective effect of insulin on ischemic renal injury in diabetes mellitus Kidney Int. 61 2002 1383 1392
32. J. Melin, O. Hellberg, K. Funa, R. Hallgren, E. Larsson, and B.C. Fellstrom Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats Nephron Exp. Nephrol. 103 2006 e86 e94
33. Z. Kurcer, H. Parlakpinar, N. Vardi, S. Tasdemir, M. Iraz, E. Fadillioglu, F. Baba, and M. Gul Protective effects of chronic melatonin treatment against renal ischemia/reperfusion injury in streptozotocin-induced diabetic rats Exp. Clin. Endocrinol. Diabetes 115 2007 365 371
34. Z. Haskova, B. Hoang, G. Luo, L.A. Morgan, A.N. Billin, F.C. Barone, B.G. Shearer, M.E. Barton, and K.S. Kilgore Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742 Inflamm. Res. 57 2008 314 321
35. L. Piqueras, M.J. Sanz, M. Perretti, E. Morcillo, L. Norling, J.A. Mitchell, Y. Li, and D. Bishop-Bailey Activation of PPAR{beta}/{delta} inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release J. Leukocyte Biol. 86 2009 115 122
36. M. Ascon, D.B. Ascon, M. Liu, C. Cheadle, C. Sarkar, L. Racusen, H.T. Hassoun, and H. Rabb Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes Kidney Int. 75 2009 526 535
37. J.A. Leslie, and K.K. Meldrum The role of interleukin-18 in renal injury J. Surg. Res. 145 2008 170 175
38. M.L. Kielar, R. John, M. Bennett, J.A. Richardson, J.M. Shelton, L. Chen, D.R. Jeyarajah, X.J. Zhou, H. Zhou, B. Chiquett, G.T. Nagami, and C.Y. Lu Maladaptive role of IL-6 in ischemic acute renal failure J. Am. Soc. Nephrol. 16 2005 3315 3325
39. H. Wu, M.L. Craft, P. Wang, K.R. Wyburn, G. Chen, J. Ma, B. Hambly, and S.J. Chadban IL-18 contributes to renal damage after ischemia-reperfusion J. Am. Soc. Nephrol. 19 2008 2331 2341
40. N.S. Patel, P.K. Chatterjee, R. Di Paola, E. Mazzon, D. Britti, A. De Sarro, S. Cuzzocrea, and C. Thiemermann Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion J. Pharmacol. Exp. Ther. 312 2005 1170 1178
41. M. Kurdi, and G.W. Booz Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling J. Cardiovasc. Pharmacol. 50 2007 126 141
42. N. Suleman, S. Somers, R. Smith, L.H. Opie, and S.C. Lecour Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning Cardiovasc. Res. 79 2008 127 133
43. W.P. Arend, G. Palmer, and C. Gabay IL-1, IL-18, and IL-33 families of cytokines Immunol. Rev. 223 2008 20 38
44. T. Kino, K.C. Rice, and G.P. Chrousos The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition Eur. J. Clin. Invest. 37 2007 425 433
45. W.S. Alexander Suppressors of cytokine signalling (SOCS) in the immune system Nat. Rev. Immunol. 2 2002 410 416